Incisive Health

<
>
How to read and use this data card.
LOADING...
1717450
e7d822ca1e8242888bcfe3db205ec170

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

500,000€ - 599,999€

Financial year: 01/01/2019 - 01/09/2019

Lobbyists declared: 8.5 FTE (11)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.

5
1
1
1

Lobbyists with EP accreditation: 0

Meetings with European Commission: 0

Lobbying costs over the years:

1
5
10
100
1000

Incisive Health

Registration on EU Transparency Register

786297415977-28 (First registered: 09 Feb 2015)

Goals / Remit

Incisive Health is a leading force in health policy and communications. In a healthcare environment that is noisy, changing rapidly and where decision-makers are under intense pressure, policy communications need to be incisive to make an impact.

Our work in Brussels focuses on supporting pan-European healthcare campaigns, engaging in Europe-wide clinical advocacy and leading policy communications in areas of EU competence.

Our team is made up of people with extensive experience of the European Commission and the European Parliament, and has a close knowledge of the EU regulatory landscape and how it impacts on healthcare delivery in EU member states.

We know how to cut through the noise and competing priorities to deliver results that enhance our clients' businesses and reputations and – ultimately – improve healthcare for patients.

Issues

Incisive Health provides strategic advice on EU policy developments and on engagement with the EU policymaking process in the public health field. We also support pan-European campaigns to improve patient care across EU member states. Our focus is on healthcare and public health matters in the EU regulatory environment and other issues - such as those affecting the economy, enterprise, information, the internal market, research and technology, and trade - to the extent that they impact these matters. As such, we work with EU policymakers on topics such as access to medicines, pharmaceutical policy, cross-border healthcare, patients’ rights and safety, digital health, market access issues, intellectual property rights, health funding, innovation, research and development in health, the impact of other EU policies on health. Incisive health works on EU policies related to healthcare and public health matters including on initiatives and legislative files on the following topics: - access to medicines, - pharmaceutical policy, - cross-border healthcare, - patients’ rights and safety, - digital health, - market access issues, - intellectual property rights, - health funding, - innovation, research and development in health, - the impact of other EU policies on health.

Address

Head office:
51 Welbeck Street
London W1G 9HL
United Kingdom

Tel: 44 02034356100

Belgium office:
Avenue Louise 54
Brussels 1050,
Belgium

Tel: 32 028939739